Xilas Gets $880,000 Grant to Advance New Device for Diabetics

Xilas Medical said that the National Institutes of Health (NIH) awarded the local company an $880,000 grant to conduct Phase II clinical trials on its TempTouch RM infrared temperature remote-monitoring device. The grant will be spent over the next 24 months. Xilas completed a Phase I NIH-sponsored trial on this device in late 2003. The FDA approved an earlier version of Xilas' TempTouch medical device last week. That product allows diabetic patients to monitor the temperature level of their feet. Elevated foot temperatures are a possible sign of inflammation and ulceration. Foot ulcers could lead to amputation in diabetics.

San Antonio Business Journal (http://sanantonio.bizjournals.com/sanantonio/stories/2005/04/04/daily2.html)